Brief: China Regenerative Medicine International Expects FY Loss Attributable
11/03/2019 12:52
March 11 (Reuters) - China Regenerative Medicine
International Ltd 8158.HK :
* GROUP IS EXPECTED TO RECORD A SIGNIFICANT LOSS
ATTRIBUTABLE FOR
YEAR
Source text for Eikon: urn:newsml:reuters.com:*:nHKSb2JCfb
Further company coverage: 8158.HK
(Reuters.Briefs@thomsonreuters.com)
Recent news on China Regenerative Medicine International
See all newsBrief: China Regenerative Medicine International Expects FY Profit To Increase At Least 28%
Brief: China Regenerative Medicine International Says Yan Shibin Will Be Appointed As CFO
Brief: China Regenerative Medicine International Posts H1 Revenue Of HKD59.78 Mln
Brief: China Regenerative Medicine International Posts FY Loss Attributable HK$107.7 Mln
Brief: China Regenerative Medicine International Says Subscription Of Increased Registered Capital